HER2-directed dendritic cell vaccine

· H. Lee Moffitt Cancer Center and Research Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HER2-directed dendritic cell vaccine, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer [EARLY_Phase 1]